Truist Financial Maintains Fortrea Holdings(FTRE.US) With Hold Rating, Maintains Target Price $7
Truist Financial Initiates Fortrea Holdings(FTRE.US) With Hold Rating, Announces Target Price $7
Cautious Hold Rating for Fortrea Holdings Amidst Execution Challenges and Industry Uncertainty
TD Cowen Maintains Fortrea Holdings(FTRE.US) With Hold Rating, Cuts Target Price to $7
BofA Securities Adjusts Price Target on Fortrea to $6 From $10
Barclays Downgrades Fortrea Holdings(FTRE.US) to Sell Rating, Cuts Target Price to $6
Barclays Downgrades Fortrea to Underweight From Equalweight, Cuts Price Target to $6 From $12
Mizuho Securities Maintains Fortrea Holdings(FTRE.US) With Hold Rating, Announces Target Price $10
Fortrea Holdings Is Maintained at Neutral by Mizuho
Fortrea Holdings Analyst Ratings
Fortrea Holdings Inc. (FTRE) Receives a Hold From Citi
TD Cowen Maintains Fortrea Holdings(FTRE.US) With Hold Rating, Cuts Target Price to $11
Cautious Hold Rating for Fortrea Holdings Inc.: Navigating Transition and Growth Challenges
Analysts Offer Insights on Healthcare Companies: Fortrea Holdings Inc. (FTRE) and Evolus (EOLS)
Evercore Maintains Fortrea Holdings(FTRE.US) With Hold Rating, Cuts Target Price to $15
Evercore ISI Sticks to Their Hold Rating for Fortrea Holdings Inc. (FTRE)
Goldman Sachs Maintains Neutral on Fortrea Holdings, Lowers Price Target to $11
TD Cowen Maintains Fortrea Holdings(FTRE.US) With Hold Rating, Cuts Target Price to $20
A Quick Look at Today's Ratings for Fortrea Holdings(FTRE.US), With a Forecast Between $10 to $12
Fortrea Holdings Is Maintained at Equal-Weight by Barclays